Arsenic Exposure and Haematological Derangement in Cervical Cancer Cases in India

  • Kumar, Rahul (National Institute of Pharmaceutical Education & Research) ;
  • Trivedi, Vinita (Mahavir Cancer Sansthan & Research Centre) ;
  • Murti, Krishna (National Institute of Pharmaceutical Education & Research) ;
  • Dey, Akalanka (National Institute of Pharmaceutical Education & Research) ;
  • Singh, Jitendra Kumar (S.S.Hospital & Research Centre) ;
  • Nath, A (S.S.Hospital & Research Centre) ;
  • Das, P (Rajendra Memorial Research Institute of Medical Sciences)
  • Published : 2015.10.06


Cervical cancer is the second most common gynecological malignancy worldwide. According to HPV Information Centre, Spain (Aug'2014), in India approximately 1,22,844 women are diagnosed with the disease every year and of them 67,477 die due to the disease. CaCx is said to be mediated by HPV but recent data published reveal the role of Oxidative Stress in different Cancers. Arsenic is also one of the agents for causing Oxidative Stress. Arsenic has been linked with different types of cancer. Arsenic is considered responsible for generation of free radicals and eventually for apoptosis. Early diagnosis of CaCx is presently a matter of concern and clinical presentation in advanced stages become difficult for complete clinical response. For determination of oxidative stress, Malondialdehyde (MDA) was taken as an identifier and arsenic estimation was performed with the help of Atomic Absorption Spectrometer (AAS). RBC count and Haemoglobin levels were performed according to standard protocol. MDA was in direct proportion with arsenic concentration and inversely proportional to RBC and Haemoglobin in CaCx patients. Arsenic is one of the major causative agents for oxidative stress and hence may be a risk factor leading to cancer including CaCx.


Arsenic;LPO;RBC;WBC;cervical cancer


  1. Belda-Iniesta C, Casado E, Cejas P, et al (2004). Implication of oxidative stress and cell membrane lipid peroxidation in human cancer (spain). Cancer Causes Control, 25, 707-719
  2. Bookemeyer C, Hartmann JT, Oechsle K (2002). Treatmentinduced anemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer. Br J Cancer, 87, 1066-71.
  3. Beevis SS, Geeha A, Rasheed MH (2007). Evidence of oxidative and nitosative stress in patients with cervical squamous cell carcinoma. Clin Chem Acta, 375, 119-23.
  4. Bhadauria S, Kannan GM, Singh N Flora SJS (2007). Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation, a review. J Environ Biol, 28, 333-47.
  5. Barrionuevo - Rosas L, Bruni L, Serrano B, et al (2014). Human papillomavirus and related diseases in india. information centre on HPV and cancer (HPV information cancer), Summary Report, 2014.
  6. Bartsch H, Nair J, Nair V (2007). Lipid peroxidation - induced DNA damage in cancer prone inflammatory diseases - a review of published adduct types and levels inhumans. Free Radic Biol Med, 43, 1109-20
  7. Bray F, Ferlay J, Parkin DM, et al (2005). Global cancer statistics, 2002, J CA Cancer Jclin, 55, 74-108
  8. Bergmann H, Holzinger S, Lippmann B, Mascher R (2002). Arsenate toxicity: effects on oxidative stress response molecules and enzymes in red clover plants. Plant Sci, 163, 961-9.
  9. Cork A, Guis D, Wink DA, et al (2004). Oxidative stress, redox and the tumor microenvironment. Semin Radiat Oncolo, 14, 259-66.
  10. Dalle-Donne I, Giustarini D, Ross R, et al (2008). Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta, 329, 23-38.
  11. Kailaivani Sailaja J, Nalini Manju VN (2002). Circulating lipid peroxidation and antioxidant status in cervical cancer patients :a case control study, Clin Biochem, 35, 621-5
  12. Kolanjipanna K, Kayalvizhi M, Manoharan S (2004). Enhanced lipid peroxidation and impaired enzymatic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett, 9, 699-707.
  13. Kumar R, Nath A, Trivedi V, et al (2015). MDA elevation and haematological derangements at first clinical presentation in cervical cancer patients. Int J Pharm Sci Rev Res, 30, 175-9
  14. Kumar M, Sharma A, Sharma MK (2007). Protective effect of menthe piperita against arsenic-induced toxicity in liver of swiss albino mice. Basic Clin Pharmacol Toxicol, 100, 249-257.
  15. Liu W-D, Liu Y-H, Liu Z-C, et al (2015). Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev, 16, 3893-900
  16. Mandal BK, Suzuki KT (2002). Arsenic round the world: a review. Talanta, 58, 201-35.
  17. Moss and Martin J Blaser, Steven F, et al (2005). Mechanisms of disease inflammation and the origins of cancer. Nat Clin Pract Oncol, Vol.2, NO 2.
  18. Ohkawa H, Shishi N, Yagi K (1995). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 979, 351-8.
  19. Pawin P, Siriwan S, Supattra S, et al (2015). Knowledge, attitudes and practices regarding cervical cancer screening among village health volunteers Asian Pac J Cancer Prev, 16, 2895-8.
  20. Panayiotidis M (2008). Reactive oxygen species (ROS) in multistage carcinogenesis, Cancer Lett, 266, 3-5.

Cited by

  1. Histopathology of Cervical Cancer and Arsenic Concentration in Well Water: An Ecological Analysis vol.14, pp.10, 2017,
  2. Arsenic toxicity and epimutagenecity: the new LINEage vol.30, pp.4, 2017,
  3. The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer pp.07302312, 2018,